Resistance Exercise Decreases Amyloid Load and Modulates Inflammatory Responses in the APP/PS1 Mouse Model for Alzheimer’s Disease

• Published in: Journal of Alzheimer's disease 2020-01, Vol.73 (4), p.1525-1539
• Main Authors: Hashiguchi, Debora, Campos, Henrique Correia, Wuo-Silva, Raphael, Faber, Jean, Gomes da Silva, Sérgio, Coppi, Antonio Augusto, Arida, Ricardo Mario, Longo, Beatriz Monteiro
• Format: Article
• Language: English
• Subjects: Alzheimer Disease - genetics; Alzheimer Disease - pathology; Alzheimer's disease; Amyloid - metabolism; Amyloid beta-Protein Precursor - genetics; Animals; Body Burden; Cytokines; Cytokines - metabolism; Genotype; Hippocampus; Hippocampus - pathology; Humans; Hyperactivity; Inflammation; Inflammation - pathology; Interleukin 4; Interleukin 6; Load resistance; Locomotor activity; Male; Mice; Mice, Transgenic; Microglia; Motor Activity; Neurodegenerative diseases; Physical Conditioning, Animal; Physical exercise; Presenilin 1; Presenilin-1 - genetics; Resistance Training; Senile plaques; Signs and symptoms
• ISSN: 1387-2877; 1875-8908
• DOI: 10.3233/JAD-190729

Neuroinflammation has been shown to play a crucial role in the development of Alzheimer’s disease (AD) and also has an association with amyloid-β (Aβ) plaques, a hallmark of this disease. Physical exercise has emerged as an alternative treatment for pathological impairment in AD. In light of this evidence, together with the fact that the hippocampus is one of the first structures to be affected in AD, we analyzed hippocampal changes in Aβ load, inflammatory responses, and locomotor activity in transgenic APP/PS1 mouse model for AD submitted to a resistance exercise (RE) program. One month after the start of the RE program, the locomotor hyperactivity related to AD behavior was reduced and microglia recruitment was increased, which in turn may have contributed to the decrease in the volume of Aβ plaques. In addition, the RE program restored the levels of IL-1α, IL-4, and IL-6 cytokines to control levels. Our study indicates that RE has beneficial effects on the locomotor behavior, amyloid burden, and inflammation of AD pathology and can therefore be used as a therapy to improve the clinical symptoms and neurophysiological alterations in AD. To the best of our knowledge, this is the first study to use a resistance exercise program in transgenic AD model.